FDA.reportPublic FDA data

NDC 72572-055-01 - Cefazolin

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
72572-055
Requested NDC
72572-055-01
Package NDCs from labels
72572-055-01, 72572-055-25
Manufacturer
Civica, Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A. | HIKMA FARMACEUTICA (PORTUGAL), S.A
Effective date
2026-05-14
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
CEFAZOLIN FOR INJECTION, USPCivica, Inc. | HIKMA FARMACEUTICA (PORTUGAL), S.A. | HIKMA FARMACEUTICA (PORTUGAL), S.A2026-05-14HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
72572-055-01Cefazolin1 in 1 VIALINJECTION, POWDER, FOR SOLUTION14
72572-055-25Cefazolin25 in 1 CARTONINJECTION, POWDER, FOR SOLUTION254

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
72572-055CEFAZOLIN INJECTION, POWDER, FOR SOLUTION [CIVICA, INC.]1Current NDC, Legacy NDC, 2 package rows20220305_9ea55207-6d86-401e-b9b9-73c9534a233f.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
72572-055-01EA - Each72572-05572c059dd-b0cf-4dd9-a5a5-2dbfa29d7d0512022-08-04
72572-055-25EA - Each72572-05557937374-8a59-40f1-82c9-4ed3730cc82012022-08-04

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 32 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CefazolinCEFAZOLINHikma Pharmaceuticals USA Inc.26de1ce9-06a9-486f-b27d-2ac635f018d12026-05-14Warnings, Adverse reactionsExact identifier
application number: ANDA065047
rxcui: 1665050
unii: P380M0454Z
CefazolinCEFAZOLINCivica, Inc.9ea55207-6d86-401e-b9b9-73c9534a233f2026-05-14Warnings, Adverse reactionsExact identifier
application number: ANDA065047
ndc (package): 72572-055-25
ndc (package): 72572-055-01
ndc (product): 72572-055
ndc11 (package): 72572005501
rxcui: 1665050
spl id: 445a305c-7f6c-4500-befa-85be0b15cf15
spl set id: 9ea55207-6d86-401e-b9b9-73c9534a233f
unii: P380M0454Z
CefazolinCEFAZOLINHikma Pharmaceuticals USA Inc.1dc9de56-e259-4546-a1db-23119a8a088e2026-05-14Warnings, Adverse reactionsExact identifier
application number: ANDA065047
rxcui: 1665050
unii: P380M0454Z
CefazolinCEFAZOLINWG Critical Care, LLC4f3a9248-a354-4c77-bf5b-9eed38f002192026-02-27Warnings, Adverse reactionsExact identifier
unii: P380M0454Z
CefazolinCEFAZOLINHospira, Inc62441488-fc97-4535-a249-4485fb0750222026-01-21Warnings, Adverse reactionsExact identifier
rxcui: 1665050
unii: P380M0454Z
CefazolinCEFAZOLINWG Critical Care, LLC00dd6da7-50a8-44c9-b2dc-7948973df3922026-01-07Warnings, Adverse reactionsExact identifier
rxcui: 1665050
unii: P380M0454Z
CefazolinCEFAZOLINCivica, Inc.c24e604f-16ca-4945-8e9d-277cc67a8c682025-11-20Warnings, Adverse reactionsExact identifier
unii: P380M0454Z
CefazolinCEFAZOLINCivica, Inc.1367568c-7d27-479f-a4c5-58e99942f6862025-11-01Warnings, Adverse reactionsExact identifier
unii: P380M0454Z
CEFAZOLINCEFAZOLINHenry Schein, Inc.197d5702-2c20-480e-8246-4d0d21f871be2025-10-27WarningsExact identifier
application number: ANDA065047
rxcui: 1665050
unii: P380M0454Z
CEFAZOLINCEFAZOLINHenry Schein Inc.922fb1a1-ad4c-4a12-8d5d-00fe13af18e82025-10-27Warnings, Adverse reactionsExact identifier
application number: ANDA065047
unii: P380M0454Z
CEFAZOLINCEFAZOLINHenry Schein, Inc.5a8c4bb2-a75e-4d7d-91fb-9a95f04fc94b2025-10-27Warnings, Adverse reactionsExact identifier
rxcui: 1665050
unii: P380M0454Z
CefazolinCEFAZOLINProPharma Distribution3d5cc73c-8a41-b285-e063-6294a90a609f2025-08-27Warnings, Adverse reactionsExact identifier
rxcui: 1665050
unii: P380M0454Z
CefazolinCEFAZOLINHikma Pharmaceuticals USA Inc.570d2583-9ce7-4941-bf7c-6ebc783c0f2b2025-07-25Warnings, Adverse reactionsExact identifier
unii: P380M0454Z
CefazolinCEFAZOLINApotex Corp.0422fe47-c372-494f-bac2-612f550b44a42025-07-15Warnings, Adverse reactionsExact identifier
rxcui: 1665050
unii: P380M0454Z
CefazolinCEFAZOLINWG Critical Care, LLCf17160d4-fc42-4f9c-abb8-d04f01ae6dd12025-04-07Warnings, Adverse reactionsExact identifier
rxcui: 1665050
unii: P380M0454Z
Cefazolin SodiumCEFAZOLIN SODIUMB. Braun Medical Inc.17f8f038-c204-4dab-80d7-6f7ac41ddbec2025-03-10Warnings, Adverse reactionsExact identifier
rxcui: 1665050
unii: P380M0454Z
CefazolinCEFAZOLINSandoz Inc18e7366a-1b3e-4010-8f4a-dd559d4f21462025-02-05Warnings, Adverse reactionsExact identifier
rxcui: 1665050
unii: P380M0454Z
CEFAZOLINCEFAZOLIN SODIUMSamson Medical Technologies, L.L.C.cf13db9c-d8a1-489f-9aa0-fc70839d4bbc2025-01-08Warnings, Adverse reactionsExact identifier
unii: P380M0454Z
CefazolinCEFAZOLINHikma Pharmaceuticals USA Inc.6c7761d3-c154-4802-9876-627cd42913f02024-12-31Warnings, Adverse reactionsExact identifier
unii: P380M0454Z
Cefazolin SodiumCEFAZOLIN SODIUMDirect_rx22dfc2e4-07a7-8d13-e063-6394a90a3e9f2024-09-24Warnings, Adverse reactionsExact identifier
rxcui: 1665050
unii: P380M0454Z

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.